What is ABECMA? ABECMA (idecabtagene vicleucel) is a prescription medicine for the treatment of multiple myeloma in patients who have received at least three kinds of treatment regimens that have not worked or have stopped working. ABECMA is a medicine made from your own white blood cells; the cells are genetically modified to recognize and attack your multiple myeloma cells.

This website is best viewed using the horizontal display on your tablet device.

This website is best viewed using the vertical display on your mobile device.

Cell Therapy 360® logo

Cell Therapy 360: Your partner
throughout the CAR T cell
therapy treatment journey

CAR=chimeric antigen receptor.

If a CAR T cell therapy treatment center decides a Bristol Myers Squibb CAR T cell therapy is right for you, Cell Therapy 360 offers solutions-oriented programs for you and your caregiver. The assistance programs are designed to support you throughout your treatment journey. Eligibility requirements may apply.

A dedicated Patient
Support Navigator

If you are receiving Bristol Myers Squibb CAR T cell therapy and you choose to enroll in the Cell Therapy 360 Patient Support Program, you will be assigned a personal Patient Support Navigator to provide customized solutions and support throughout your treatment journey.

Logistical support

Cell Therapy 360 may be able to support eligible patients* and a caregiver with transportation, lodging, and meal assistance throughout the patient journey.

*Eligibility requirements apply.

Financial support

Through the Copay Assistance Program, Cell Therapy 360 can cover out-of-pocket expenses for commercially insured patients for the Bristol Myers Squibb CAR T cell therapy product.

The program is not available for patients who are enrolled in Medicare, Medicaid, TRICARE, the Veterans Affairs (VA), or any other federal or state healthcare program. The program will cover out-of-pocket expenses of the Bristol Myers Squibb product only. Limitations apply. It does not cover the costs of any other healthcare provider charges or any other treatment costs. Patients are responsible for non-drug-related-out-of-pocket costs. Additional eligibility requirements may apply. Bristol Myers Squibb reserves the right to rescind, revoke, or amend this program without notice.

To learn more about Cell Therapy 360:

To learn more about Cell Therapy 360:

Find a certified treatment
center near you

Find a location

Register for more information
about ABECMA

register now